Senseonics Holdings, Inc. Schedules Third Quarter 2018 Earnings Release and Conference Call for November 8, 2018 at 4:30 p.m. Eastern Time
GERMANTOWN, Md.--(BUSINESS WIRE)--
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology
company focused on the development and commercialization of a long-term,
implantable continuous glucose monitoring (CGM) system for people with
diabetes, today announced that it plans to release its third quarter
2018 financial results after market close on Thursday, November 8, 2018.
Management will hold a conference call to review the company’s third
quarter 2018 performance starting at 4:30 p.m. (Eastern Time) on the
same day. The conference call will be concurrently webcast. The link to
the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com
by navigating to “Investor Relations,” and then “Events & Publications,”
and will be archived there for future reference. To listen to the
conference call, please dial 1-877-883-0383 (US/Canada) or
1-412-902-6506 (International), Participant Elite Entry Number 2105036,
approximately ten to five minutes prior to start time.
About Senseonics
(NYSE American: SENS) is a medical technology company focused on the
design, development and commercialization of transformative glucose
monitoring products designed to help people with diabetes confidently
live their lives with ease. From its inception, Senseonics has been
advancing the integration of novel, fluorescence sensor technology with
smart wearable devices. The Eversense® CGM System received PMA approval
from the FDA for up to 90 days of continuous use and is available in the
United States. The Eversense® CGM XL System received CE mark for up to
180 days of continuous use and is available in Europe. For more
information on Senseonics, please visit www.senseonics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181015005882/en/
INVESTOR CONTACT
Senseonics Holdings, Inc.
R. Don
Elsey, 301-556-1602
Chief Financial Officer
[email protected]
Source: Senseonics Holdings, Inc.